Drug Database
LE

levonorgestrel (LCS12 / LCS G04209C / MLS)

✓ Approved

Takeda · PGR · 小分子

什么是 levonorgestrel?

levonorgestrel 是一种小分子,由Takeda研发。该药已获批,用于治疗相关适应症,给药途径:Surgical Implantation。

药物档案

商品名LCS12, LCS G04209C, MLS
公司Takeda
药物类别小分子
分子靶点PGR
给药途径Surgical Implantation
状态Approved

作用机制

分子靶点

levonorgestrel 作用于 1 个分子靶点:

PGRprogesterone receptor (NR3C3, PR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

levonorgestrel 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Reproductive system and breast disordersMenstrual disorder✓ Approved
Reproductive system and breast disordersHeavy menstrual bleeding✓ Approved

相关研究文献

PubMedOpen access journal of contraception2026-11-18

Prevalence and Predictors of Intrauterine Device Failure Among Women in Sub-Saharan Africa: A Scoping Review.

Nanyiri Job J

Although highly effective in unintended pregnancy prevention, intrauterine device uptake remains perennially low in sub-Saharan Africa, partly due to the perceived risk of device failure, whose prevalence and predictors remain poorly understood in the sub-regional context. To assess the prevalence and predictors of intrauterine device failure (IUDF) in women in sub-Saharan Africa. A scoping review approach was used, with comprehensive searches conducted in ten databases: ProQuest, EBSCO, PubMed, ScienceDirect, MEDLINE, Ovid EMBASE, CINAHL, PsycINFO, Web of Science, and Google Scholar. The search was guided by article saturation to minimize duplication. The Population (P), concept (C), and context (C) approaches were used to set the eligibility criteria, and data were analyzed using descriptive frequency counting and content analysis. Of the 51 studies identified through the search strategy, only six full-text articles met the eligibility criteria. Only five of these studies quantified the prevalence of Intrauterine Device (IUD) failure, which ranged from 0.2% to 7.4%, with the highest reported in Ethiopia. Only three studies reported predictors of IUD failure, including nationality, increasing parity, mispositioning during insertion, small uterine cavity, and IUD fitting by less experienced healthcare workers. Over the past 10 years, very few studies in sub-Saharan Africa have credibly estimated the prevalence of IUD failure or identified predictors of IUD failure. Only six studies made such an attempt; however, none were designed with methodological rigor to allow credible quantification of the prevalence of IUD failure. Although all six studies included IUD failure as an outcome, none explicitly examined the predictors of IUD failure. Nonetheless, the few available studies indicate that IUD failure is a reality, with significant variation across regions ranging from 0.2% to 7.4%. Both intrapersonal and service provision characteristics predict IUD failure, with the service provision factors taking precedence.

PMID 43048590
阅读全文 →
PubMedThe European journal of contraception & reproductive health care : the official journal of the European Society of Contraception2026-11-16

Factors associated with long-acting reversible contraceptive choice following voluntary termination of pregnancy.

Xu Susana S, Damião Sara Margarida Pacheco SMP, Milhinhos Cláudia Raquel Fernandes CRF, Arruda Sara Alves Pereira Marques SAPM et al.

To identify sociodemographic, reproductive and healthcare-related factors independently associated with long-acting reversible contraception (LARC) choice following voluntary termination of pregnancy (VTP). A retrospective observational study was conducted at a VTP Unit in a Portuguese tertiary-care hospital between January 2025 and January 2026. Variables included age, ethnicity, educational level, occupational status, access to a family physician, attendance at a family planning consultation during the previous year, contraceptive method used before the index pregnancy, parity and previous VTP. The primary outcome was LARC choice following VTP. Of 1,025 women assessed, 860 were included [median age 27 years (23-32)]; Among these, 482 (56.0%) selected a LARC: 233 (48.3%) chose a 52 mg LNG-IUD, 226 (46.9%) an ENG implant and 23 (4.8%) a Cu-IUD. In the multivariable analysis, younger age, higher parity, and occupational status were independently associated with LARC choice (p < 0.05). Each five-year increase in age was associated with a 24% reduction in the odds of LARC selection (aOR 0.76, p < 0.001). Younger age, higher parity and occupational status were independently associated with LARC choice. These findings may contribute to understanding post-VTP contraceptive patterns and identify areas for further research on contraceptive choice.

PMID 43037531
阅读全文 →
PubMedFP essentials2026-11-16

Menstrual Disorders: Premenopausal Abnormal Uterine Bleeding.

Paruchuri Bindusri B, Miller Amanda A

Abnormal uterine bleeding is a common and distressing concern for reproductive-aged females, potentially leading to long-term consequences such as iron deficiency anemia if not properly addressed. The International Federation of Gynecology and Obstetrics defines abnormal uterine bleeding as bleeding occurring outside the normal frequency of every 24 to 38 days, with additional criteria based on cycle length, regularity, and flow volume. Etiologies are classified using the PALM-COEIN system, which separates structural causes (polyp, adenomyosis, leiomyoma, and malignancy and hyperplasia) from nonstructural causes (coagulopathy, ovulatory dysfunction, endometrial disorders, iatrogenic factors, and conditions not otherwise classified). Transvaginal and transabdominal Doppler ultrasonography are the recommended initial diagnostic modalities for structural etiologies, and magnetic resonance imaging may be used if findings are inconclusive. Endometrial sampling is indicated in patients at increased risk for endometrial pathology, including those with obesity, chronic anovulation, a family history of malignancy, or age of 45 years or older. Management options include medical and surgical therapies. The levonorgestrel-releasing intrauterine system is a highly effective medical treatment, whereas hysterectomy remains the most definitive option, particularly for patients who have completed childbearing. Medical management adequately controls symptoms for many, although structural conditions often require procedural or surgical intervention.

PMID 43037956
阅读全文 →
PubMedJournal of clinical medicine2026-11-14

Advances in Intrauterine Contraception and Therapeutic Intrauterine Devices, 2016-2026: A Targeted Scoping Review.

Biriș Marius M, Buciu Victor Bogdan VB, Cîtu Ioana Mihaela IM, Pescaru Andrei A et al.

Intrauterine contraception has changed over the past decade through longer validated duration, lower-dose hormonal devices, redesigned copper devices, new indications, and better safety surveillance. This targeted scoping review (OSF registration 10.17605/OSF.IO/3GUQF) mapped English-language primary human studies published from 1 January 2016 to 5 September 2026 in journals indexed in the Science Citation Index Expanded (SCIE). A reproducible search targeted to the major device programs, randomized trials, and large surveillance cohorts identified 766 PubMed/MEDLINE records, with no additional unique records from Scopus or Web of Science; of the 624 unique records screened, 123 reports were assessed, and 114, from 66 distinct trials, cohorts, or data sources, were included and appraised with design-specific Joanna Briggs Institute (JBI) tools. Two single-arm programs and a 7-year randomized trial supported the efficacy of 52 mg levonorgestrel intrauterine devices (LNG-IUDs) through 8 years. Lower-dose LNG-IUDs eased placement but were associated with higher ectopic pregnancy rates in four Scandinavian analyses and with less antidepressant use than the 52 mg device. Smaller or size-matched copper devices improved continuation and reduced expulsion in randomized comparisons, whereas a low-copper nitinol device had a higher 5-year pregnancy rate than expected with TCu380A. Perforation was uncommon but more frequent after postpartum insertion and during breastfeeding; immediate postpartum insertion carried the highest expulsion risk. One randomized trial and its secondary analyses supported the 52 mg LNG-IUD for emergency contraception. Therapeutic evidence was strongest for heavy menstrual bleeding and endometrial hyperplasia, whereas intrauterine ball and precious metal designs showed no consistent benefit. Progress refined rather than replaced the T-shaped IUD.

PMID 43030483
阅读全文 →
PubMedThe European journal of contraception & reproductive health care : the official journal of the European Society of Contraception2026-11-13

Technical difficulty of levonorgestrel 52-mg intrauterine device placement and six-month clinical outcomes among women with and without isthmocele: a prospective cohort study.

Laporte Montas M, Marcelino Ana C AC, Juliato Cássia R T CRT, Bahamondes Luis L

To compare pain and difficulty during levonorgestrel 52-mg intrauterine device (LNG 52-mg IUD) insertion in women with and without isthmocele and, secondarily, to assess changes in uterine bleeding, and chronic pelvic pain six months after insertion. Our prospective study was conducted at the Universidade Estadual de Campinas, Brazil. Women aged 18-43 years with at least one caesarean delivery ≥6 months previously, with or without ultrasound-diagnosed isthmocele, were included. Insertion pain, menstrual pain, and chronic pelvic pain were assessed using a 100-mm visual analogue scale (VAS). We included 260 women (103 with and 157 without isthmocele), providing 80% power at α = 0.05 to detect differences in insertion outcomes. Multivariable logistic regression identified factors associated with insertion difficulty and severe pain. Insertion success was similar in women with and without isthmocele (99.0% vs. 98.7%; p = 1.000), as were pain intensity (p = 0.80) and insertion difficulty (p = 0.19). Of 224 women reporting at least one symptom at baseline, 89 (39.7%) had isthmocele and 135 (60.3%) did not. At six months, both groups showed significant reductions in heavy menstrual bleeding, menstrual pain, and chronic pelvic pain (all p < 0.001). Prolonged menstrual bleeding (≥8 days) decreased significantly among women with isthmocele; however, the group-by-time interaction was not significant (p = 0.21). Isthmocele was not associated with greater insertion pain or difficulty. Six months after LNG 52-mg IUD insertion, both groups showed improvements in heavy menstrual bleeding, menstrual pain, and chronic pelvic pain. Isthmocele was not associated with greater insertion pain or difficulty of the LNG 52-mg IUD. Six months after IUD insertion, both groups showed improvements in heavy menstrual bleeding, menstrual pain, and chronic pelvic pain.

PMID 43023222
阅读全文 →
PubMedBMC women's health2026-11-13

Variation of the uterine flexion angle before and after voiding in nulliparous women with anteverted uterus: FLEXIMIX study.

Chiron Benoît B, Aujoulat Paul P, Gergaud Lisa L, Fouwé Camille C et al.

Resistance during intrauterine device insertion (IUD) may be influenced by the uterine flexion angle. While bladder filling has been used to facilitate catheter insertion for hysteroscopy and embryo transfer, the only study assessing this strategy for IUD insertion found no benefit. However, the physiological effect of bladder filling on uterine alignment has not been rigorously evaluated. This effect may be particularly relevant in nulliparous women with anteverted uteri. The study aimed to evaluate the variation in uterine flexion angle between full and empty bladder conditions in nulliparous women, and to determine the prevalence of uterine anteversion in a European population. Prospective single-center study included 250 nulliparous women aged 18 years or older. Participant underwent two transabdominal ultrasounds: with a full bladder / after voiding. Uterine version and flexion were assessed by measuring the angles formed by the uterine body, cervix, and vaginal axis. Among the 215 participants with uterine anteversion (87.0%), paired flexion angle measurements were available for 212 (84.8% of the total cohort). Among these 212 women, the mean change in flexion angle was 48.0° (SD 36.7°, p < 0.001; Cohen's d = 1.31). In 60.8% of cases, bladder filling changed an acute flexion angle to an obtuse one. The point of uterine flexion was located approximately 20-21 mm from the external cervical os, just beyond the internal os, suggesting a mechanical effect of bladder distension on uterine alignment. Bladder filling significantly modifies uterine flexion in nulliparous women with anteversion. This physiological effect provides a plausible anatomical mechanism that may facilitate IUD insertion. Further interventional studies are needed to determine its clinical applicability. ClinicalTrials.gov, trial registration number: NCT06669845, registration date: 2024-10-31.

PMID 43021197
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多levonorgestrel